Enlighta Inc. operates as a healthcare and medical digital, green, and clean technology company. More Details
Excellent balance sheet and fair value.
Share Price & News
How has Enlighta's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: Insufficient data to determine NLTA's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine NLTA's volatility change over the past year.
7 Day Return
CA Healthcare Services
1 Year Return
CA Healthcare Services
Return vs Industry: NLTA underperformed the Canadian Healthcare Services industry which returned 97% over the past year.
Return vs Market: NLTA underperformed the Canadian Market which returned 37.1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Enlighta's share price compared to the market and industry in the last 5 years?
Simply Wall St News
10 months ago | Simply Wall StWhat Kind Of Shareholder Appears On The Enlighta Inc.'s (CVE:NLTA) Shareholder Register?
1 year ago | Simply Wall StEnlighta (CVE:NLTA) Will Have To Spend Its Cash Wisely
1 year ago | Simply Wall StWhat You Must Know About Enlighta Inc.'s (CVE:NLTA) Beta Value
Is Enlighta undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: NLTA (CA$0.12) is trading below our estimate of fair value (CA$0.87)
Significantly Below Fair Value: NLTA is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: NLTA is unprofitable, so we can't compare its PE Ratio to the XN Healthcare Services industry average.
PE vs Market: NLTA is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate NLTA's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: NLTA is good value based on its PB Ratio (1.3x) compared to the CA Healthcare Services industry average (8.6x).
How is Enlighta forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Enlighta has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Enlighta performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NLTA is currently unprofitable.
Growing Profit Margin: NLTA is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: NLTA is unprofitable, and losses have increased over the past 5 years at a rate of 24.8% per year.
Accelerating Growth: Unable to compare NLTA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NLTA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (18.1%).
Return on Equity
High ROE: NLTA has a negative Return on Equity (-331.39%), as it is currently unprofitable.
How is Enlighta's financial position?
Financial Position Analysis
Short Term Liabilities: NLTA's short term assets (CA$373.3K) do not cover its short term liabilities (CA$2.0M).
Long Term Liabilities: NLTA has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: NLTA is debt free.
Reducing Debt: NLTA had no debt 5 years ago.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable NLTA has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: NLTA is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 19% per year.
What is Enlighta current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NLTA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NLTA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NLTA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NLTA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NLTA's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ms. Yun Zhu, also known as Avis, serves as Chief Executive Officer and Director at Enlighta Inc. (formerly known as, HooXi Network Inc.) since October 9, 2018. Ms. Zhu serves as Chief Marketing Officer of ...
CEO Compensation Analysis
Compensation vs Market: Insufficient data to establish whether Avis's total compensation is reasonable compared to companies of similar size in the Canadian market.
Compensation vs Earnings: Insufficient data to compare Avis's compensation with company performance.
Experienced Management: NLTA's management team is seasoned and experienced (10.9 years average tenure).
Experienced Board: NLTA's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Enlighta Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Enlighta Inc.
- Ticker: NLTA
- Exchange: TSXV
- Founded: 2010
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: CA$2.050m
- Shares outstanding: 17.08m
- Website: https://www.enlightahealth.com
Number of Employees
- Enlighta Inc.
- 30 DeCastro Street
- Wickhams Cay 1
- Road Town
- British Virgin Islands
Enlighta Inc. operates as a healthcare and medical digital, green, and clean technology company. It offers virtual medical care solutions, including disease prevention, detection, interventional therapy, a...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/07 22:04|
|End of Day Share Price||2021/05/06 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.